Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Technology
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Visual Stories
  • Reviews
  • Phone Reviews
  • Fitness Bands Reviews
  • Speakers Reviews
  • Find Cricket Statistics
Hindi
More
In the news
Vladimir Putin
United States of America
North Atlantic Treaty Organization
COVID-19
Russia-Ukraine crisis
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Technology
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Visual Stories
Reviews
Phone Reviews
Fitness Bands Reviews
Speakers Reviews
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / World News / Novavax seeks 'OK' for COVID-19 vaccine in needy countries first
World

Novavax seeks 'OK' for COVID-19 vaccine in needy countries first

Novavax seeks 'OK' for COVID-19 vaccine in needy countries first
Written by Astha Oriel
(Sourced from PTI)
Aug 06, 2021, 12:22 pm 2 min read
Novavax seeks 'OK' for COVID-19 vaccine in needy countries first
Novavax is planning to produce up to 100 million COVID-19 vaccine doses a month by the end of the third quarter and 150 million doses a month by year's end

Vaccine maker Novavax announced Thursday that it has asked regulators in India, Indonesia, and the Philippines to allow emergency use of its COVID-19 vaccine—offering its shot to some low-income countries before rich ones with ample supplies. The company announced it also plans to submit applications in Britain, Europe, Australia, Canada, and New Zealand soon, but not in the US until later this year.

Details
Company will seek WHO review to become part of COVAX

US-based Novavax partnered with the Serum Institute of India plans to seek the World Health Organization review needed to be part of the COVAX global vaccine program later this month. Novavax CEO Stanley Erck called the submissions an important step toward access to millions of doses of a safe and effective vaccine for countries with an urgent need to control the pandemic.

Novavax
Novavax shots are easier to store and transport

The Novavax two-dose shot is made with lab-grown copies of the spike protein that coats the coronavirus. That's very different than other widely used vaccines that deliver genetic instructions for the body to make its own spike protein. The Novavax shots are easier to store and transport and have long been expected to play an important role in increasing supplies in poor countries.

Information
Vaccine proved to be 90% effective against symptomatic COVID-19: Novavax

In June, Novavax announced the vaccine had proved about 90% effective against symptomatic COVID-19 in a study of nearly 30,000 people in the US and Mexico. It also worked against variants circulating in those countries at the time. Side effects were mostly mild.

Delta variant
Our booster shot can tackle Delta variant: Novavax

As for the highly contagious Delta variant that now is circulating in much of the world, Novavax also announced that giving a booster six months after a second shot revved up virus-fighting antibodies that could tackle that mutant. Additional studies in Britain and elsewhere are testing if the Novavax shot could be used as a booster after other types of COVID-19 vaccines.

COVID-19 vaccine doses
Will be able to produce 150mn doses/month by year-end: Novavax

Moreover, the company has said that Indonesia already had expressed interest in using the Novavax vaccine as a booster following some Chinese-made shots. The Gaithersburg, Maryland, company said it was on track to produce up to 100 million doses a month by the end of the third quarter and 150 million doses a month by year-end.

Share this timeline
Facebook
Whatsapp
Twitter
Linkedin
Astha Oriel <br/><i>(Sourced from PTI)</i>
Astha Oriel
(Sourced from PTI)
Twitter
I am a graduate of the Indian Institute of Journalism and New Media, Bangalore. As a history buff, I am an avid reader. When I am not reading, I like to listen to classical Hollywood and Bollywood songs, learn a new language, or doodle.
Latest
India
Indonesia
Europe
Novavax
COVID-19 Vaccine
Related
Latest
Statistical comparison of 'Big Titles' between Djokovic, Federer, and Nadal
Statistical comparison of 'Big Titles' between Djokovic, Federer, and Nadal Sports
Vivo S15 Pro announced with MediaTek Dimensity 8100 SoC
Vivo S15 Pro announced with MediaTek Dimensity 8100 SoC Technology
Top 5 upcoming DC shows to look out for
Top 5 upcoming DC shows to look out for Entertainment
Vivo Y75 4G launched in India at Rs. 21,000
Vivo Y75 4G launched in India at Rs. 21,000 Technology
IPL 2022, RR beat CSK to finish second: Records broken
IPL 2022, RR beat CSK to finish second: Records broken Sports
India
COVID-19: India reports 2,364 fresh cases, 10 more deaths
COVID-19: India reports 2,364 fresh cases, 10 more deaths India
Centre eases ban on wheat export: Here are more details
Centre eases ban on wheat export: Here are more details Business
Global wheat prices surge by 6% after India's export ban
Global wheat prices surge by 6% after India's export ban Business
In surprise move, Chinese media defends India's wheat export ban
In surprise move, Chinese media defends India's wheat export ban World
COVID-19: India logs 2,202 new cases; 27 more deaths
COVID-19: India logs 2,202 new cases; 27 more deaths India
More News
Indonesia
Hockey India announces squad for 2022 Asia Cup
Hockey India announces squad for 2022 Asia Cup Sports
Hindustan Unilever hikes product prices for second time within month
Hindustan Unilever hikes product prices for second time within month Business
China: Plane crash mystery deepens as evidence suggests midair breakup
China: Plane crash mystery deepens as evidence suggests midair breakup World
Why is Indonesia shifting capital from Jakarta to Nusantara?
Why is Indonesia shifting capital from Jakarta to Nusantara? World
Indonesia issues tsunami warning after earthquake of 7.3 magnitude
Indonesia issues tsunami warning after earthquake of 7.3 magnitude World
More News
Europe
Monkeypox spreads tentacles: US, Canada, Spain and Portugal confirm cases
Monkeypox spreads tentacles: US, Canada, Spain and Portugal confirm cases World
Russia defending 'motherland' in Ukraine, says Putin on Victory Day
Russia defending 'motherland' in Ukraine, says Putin on Victory Day World
Paris meet with Macron concludes PM Modi's Europe tour
Paris meet with Macron concludes PM Modi's Europe tour World
India wants Russian crude oil for less than $70/barrel: Report
India wants Russian crude oil for less than $70/barrel: Report Business
Peace, talks only solution to Russia-Ukraine war: Modi in Berlin
Peace, talks only solution to Russia-Ukraine war: Modi in Berlin World
More News
Novavax
Serum gets nod for Novavax trial in 7-11 age group
Serum gets nod for Novavax trial in 7-11 age group India
Serum to begin Covovax trials on children in July
Serum to begin Covovax trials on children in July India
How Biological E's coronavirus vaccine could be a potential gamechanger
How Biological E's coronavirus vaccine could be a potential gamechanger India
Covovax India launch by September; trial for kids soon: SII
Covovax India launch by September; trial for kids soon: SII India
Novavax's COVID-19 vaccine is over 90% effective, firm says
Novavax's COVID-19 vaccine is over 90% effective, firm says India
More News
COVID-19 Vaccine
North Korea confirms first COVID-19 case ever, imposes nationwide lockdown
North Korea confirms first COVID-19 case ever, imposes nationwide lockdown World
COVID-19: India logs 2,927 new cases; 32 more deaths
COVID-19: India logs 2,927 new cases; 32 more deaths India
DCGI clears COVAXIN, Corbevax for children aged 6-12, 5-12 years
DCGI clears COVAXIN, Corbevax for children aged 6-12, 5-12 years India
Government considering COVID-19 booster dose for all adults: Report
Government considering COVID-19 booster dose for all adults: Report India
COVID-19 vaccination for 12-14 years begins; here's how to register
COVID-19 vaccination for 12-14 years begins; here's how to register India
More News
Related
US: Pfizer-BioNTech COVID-19 vaccine officially granted full approval by FDA
US: Pfizer-BioNTech COVID-19 vaccine officially granted full approval by FDA World
Pfizer-BioNTech COVID-19 vaccine to get US-FDA's full approval next week
Pfizer-BioNTech COVID-19 vaccine to get US-FDA's full approval next week World
COVID-19: Everything to know about Delta, Delta-Plus, Kappa, Lambda variants
COVID-19: Everything to know about Delta, Delta-Plus, Kappa, Lambda variants India
Expert panel says no to Covovax's children trials in India
Expert panel says no to Covovax's children trials in India India
Next News Article
Next News Article

Love World news?

Subscribe to stay updated.

World Thumbnail
India News Business News World News Politics News Sports News Technology News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Mukesh Ambani Indian Premier League (IPL) Karnataka Samsung Xiaomi West Bengal
Bihar Virat Kohli Rohit Sharma Haryana Narendra Modi Arvind Kejriwal Tamil Nadu Gujarat Yogi Adityanath YouTube
Instagram Hollywood News Uttar Pradesh Kerala Netflix Bollywood News Mamata Banerjee Maruti Suzuki Rahul Gandhi Elon Musk
Shah Rukh Khan Chelsea FC OPPO Akhilesh Yadav Indian Cricket Team Apple Manchester United Salman Khan Cryptocurrency OnePlus
Amitabh Bachchan ICC Women's World Cup Vivo India vs Sri Lanka
About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive IPL 2022 Schedule IPL 2022 Points Table Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2022